Attila Zalatnai Selected Research

Phosphotransferases (Kinase)

1/2015

Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Attila Zalatnai Research Topics

Disease

21	Neoplasms (Cancer) 07/2020 - 09/2003
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 09/2003
3	Adenocarcinoma 07/2020 - 01/2005
3	Carcinoma (Carcinomatosis) 08/2014 - 01/2005
2	Lymphoma (Lymphomas) 01/2015 - 02/2012
2	Glucagonoma 08/2011 - 01/2009
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Papillomavirus Infections 01/2021
1	Mouth Neoplasms (Oral Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Hyperthermia 07/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2019
1	Hyperglycemia 01/2015
1	Insulinoma 08/2014
1	Breast Neoplasms (Breast Cancer) 07/2012
1	Prostatic Neoplasms (Prostate Cancer) 07/2012
1	Leukemia 07/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2012
1	Lung Neoplasms (Lung Cancer) 02/2012
1	Necrolytic Migratory Erythema 08/2011
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 12/2010
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2010
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 12/2010
1	Pheochromocytoma 12/2010
1	Adrenocortical Adenoma (Disease, Conn's) 10/2010
1	Adenoma (Adenomas) 10/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2010
1	Vipoma (WDHA) 07/2010
1	Dehydration (Water Stress) 07/2010
1	Hyperplasia 01/2009
1	Multiple Endocrine Neoplasia Type 1 01/2009
1	Neuroendocrine Carcinoma 12/2008
1	Primary Immunodeficiency Diseases 12/2008
1	Fibrosis (Cirrhosis) 11/2006
1	Hepatocellular Carcinoma (Hepatoma) 11/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2006
1	Inflammation (Inflammations) 01/2006

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 07/2012 - 03/2007
2	Chromogranin AIBA 04/2019 - 08/2014
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2019 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2005
2	Messenger RNA (mRNA)IBA 01/2015 - 10/2010
2	Glucagon (Glukagon)FDA Link 08/2011 - 01/2009
2	ParaffinIBA 12/2010 - 12/2009
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2010 - 12/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2006 - 01/2005
2	Amino Acids FDA Link 01/2005 - 09/2003
2	MimosineIBA 01/2005 - 09/2003
2	Antineoplastic Agents (Antineoplastics)IBA 01/2005 - 01/2005
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SmokeIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 07/2020
1	Annexin A5IBA 07/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2015
1	Conditioned Culture MediaIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	EcdysteroidsIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	LigandsIBA 01/2015
1	Ecdysterone (20 Hydroxyecdysone)IBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Hormones (Hormone)IBA 08/2014
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2014
1	1,3- dimethyl- 1,3- bis(4- fluorophenyl)- 1,3- bis(3- (1- (4- butypiperazinyl))propyl)disiloxaneIBA 07/2012
1	capsanthinIBA 02/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2012
1	Carotenoids (Carotene)IBA 02/2012
1	XanthophyllsIBA 02/2012
1	capsorubinIBA 02/2012
1	Formaldehyde (Formol)FDA Link 12/2010
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2010
1	MicroRNAs (MicroRNA)IBA 12/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2010
1	glucocorticoid receptor alphaIBA 10/2010
1	Protein Isoforms (Isoforms)IBA 10/2010
1	glucocorticoid receptor betaIBA 10/2010
1	ElectrolytesIBA 07/2010
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2010
1	AcidsIBA 07/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2009
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 08/2009
1	Fluorouracil (Carac)FDA LinkGeneric 08/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2009
1	CD40 Ligand (CD40L)IBA 12/2008
1	Immunoglobulin M (IgM)IBA 12/2008
1	Silicon CompoundsIBA 03/2008
1	1,3- dimethyl- 1,3- (4- fluorophenyl)- 1,3- (3- butyl- (1- piperazinyl)propyl)- 1,3- disiloxaneIBA 03/2008
1	1,3- dimethyl- 1,3- p- fluorophenyl- 1,3- (3- morpholinopropyl)- 1,3- disiloxaneIBA 03/2008
1	AgrinIBA 11/2006
1	IntegrinsIBA 11/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2006
1	CollagenIBA 01/2006

Therapy/Procedure

2	Therapeutics 07/2020 - 01/2005
2	Radiotherapy 07/2020 - 01/2005
2	Drug Therapy (Chemotherapy) 07/2010 - 01/2006